Randomized study comparing carboplatin/cyclophosphamide and cisplatin/cyclophosphamide as first-line treatment in patients with stage III/IV epithelial ovarian cancer and small volume disease. German Ovarian Cancer Study Group (GOCA).

Meerpohl, H G; Sauerbrei, W; Kühnle, H; Schumacher, M; Pfleiderer, A

Meerpohl, H G; Sauerbrei, W; Kühnle, H; Schumacher, M; Pfleiderer, A.

Affiliation

Meerpohl HG; Department of Obstetrics and Gynecology, University of Freiburg, Germany.

Gynecol Oncol ; 66(1): 75-84, 1997 Jul.

Article in En | MEDLINE | ID: mdl-9234925

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Ovarian Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carboplatin/administration & dosage; Cisplatin/administration & dosage; Cyclophosphamide/administration & dosage; Drug Administration Schedule; Epithelium/pathology; Female; Follow-Up Studies; Humans; Middle Aged; Multivariate Analysis; Neoplasm Staging; Ovarian Neoplasms/pathology; Prospective Studies

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 1997 Document type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links